CAPS - Capstone Therapeutics Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5835.56k
Enterprise Value 3709.37M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-312.91

Trading Information

Stock Price History

Beta (3Y Monthly) 3.25
52-Week Change 3-99.97%
S&P500 52-Week Change 32.99%
52 Week High 360.0000
52 Week Low 30.0120
50-Day Moving Average 315.1619
200-Day Moving Average 322.8971

Share Statistics

Avg Vol (3 month) 327
Avg Vol (10 day) 3N/A
Shares Outstanding 554.39M
Float 27.19M
% Held by Insiders 150.20%
% Held by Institutions 14.99%
Shares Short (Jun 30, 2011) 426.56k
Short Ratio (Jun 30, 2011) 40.25
Short % of Float (Jun 30, 2011) 40.08%
Short % of Shares Outstanding (Jun 30, 2011) 40.07%
Shares Short (prior month May 31, 2011) 434.18k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Jun 26, 1996

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-95.46%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)1.75M
EBITDA -2.27M
Net Income Avi to Common (ttm)-2.59M
Diluted EPS (ttm)-0.0480
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)305k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)2.66M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.86
Book Value Per Share (mrq)-0.05

Cash Flow Statement

Operating Cash Flow (ttm)-2.04M
Levered Free Cash Flow (ttm)-1.29M